Literature DB >> 19411608

An allosteric modulator of alpha7 nicotinic receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine.

Sean C Barron1, James T McLaughlin, Jennifer A See, Vanessa L Richards, Robert L Rosenberg.   

Abstract

Nicotinic acetylcholine receptors are implicated in several neuropsychiatric disorders, including nicotine addiction, Alzheimer's, schizophrenia, and depression. Therefore, they represent a critical molecular target for drug development and targeted therapeutic intervention. Understanding the molecular mechanisms by which allosteric modulators enhance activation of these receptors is crucial to the development of new drugs. We used the substituted cysteine accessibility method to study conformational changes induced by the positive allosteric modulator N-(5-chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596) in the extracellular ligand binding domain of alpha7 nicotinic receptors carrying the L247T mutation. PNU-120596 caused changes in cysteine accessibility at the inner beta sheet, transition zone, and agonist binding site. These changes in accessibility are similar to but not identical to those caused by ACh alone. In particular, PNU-120596 induced changes in MTSEA accessibility at N170C (in the transition zone) that were substantially different from those evoked by acetylcholine (ACh). We found that PNU-120596 induced changes at position E172C in the absence of allosteric modulation. We identified a cysteine mutation of the agonist binding site (W148C) that exhibited an unexpected phenotype in which PNU-120596 acts as a full agonist. In this mutant, ACh-evoked currents were more sensitive to thiol modification than PNU-evoked currents, suggesting that PNU-120596 does not bind at unoccupied agonist-binding sites. Our results provide evidence that binding sites for PNU-120596 are not in the agonist-binding sites and demonstrate that positive allosteric modulators such as PNU-120596 enhance agonist-evoked gating of nicotinic receptors by eliciting conformational effects that are similar but nonidentical to the gating conformations promoted by ACh.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411608      PMCID: PMC2713121          DOI: 10.1124/mol.109.056226

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Refined structure of the nicotinic acetylcholine receptor at 4A resolution.

Authors:  Nigel Unwin
Journal:  J Mol Biol       Date:  2005-01-25       Impact factor: 5.469

Review 2.  Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.

Authors:  D Colquhoun
Journal:  Br J Pharmacol       Date:  1998-11       Impact factor: 8.739

3.  Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor.

Authors:  J L Galzi; S Bertrand; P J Corringer; J P Changeux; D Bertrand
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

4.  State-dependent accessibility and electrostatic potential in the channel of the acetylcholine receptor. Inferences from rates of reaction of thiosulfonates with substituted cysteines in the M2 segment of the alpha subunit.

Authors:  J M Pascual; A Karlin
Journal:  J Gen Physiol       Date:  1998-06       Impact factor: 4.086

5.  Two tyrosine residues on the alpha subunit are crucial for benzodiazepine binding and allosteric modulation of gamma-aminobutyric acidA receptors.

Authors:  J Amin; A Brooks-Kayal; D S Weiss
Journal:  Mol Pharmacol       Date:  1997-05       Impact factor: 4.436

Review 6.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

7.  Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors.

Authors:  U Günther; J Benson; D Benke; J M Fritschy; G Reyes; F Knoflach; F Crestani; A Aguzzi; M Arigoni; Y Lang; H Bluethmann; H Mohler; B Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Acetylcholine receptor channel structure probed in cysteine-substitution mutants.

Authors:  M H Akabas; D A Stauffer; M Xu; A Karlin
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

9.  Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.

Authors:  A Orr-Urtreger; F M Göldner; M Saeki; I Lorenzo; L Goldberg; M De Biasi; J A Dani; J W Patrick; A L Beaudet
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

10.  From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor.

Authors:  W Zhong; J P Gallivan; Y Zhang; L Li; H A Lester; D A Dougherty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  20 in total

1.  Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation.

Authors:  Corrie J B daCosta; Chris R Free; Jeremías Corradi; Cecilia Bouzat; Steven M Sine
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Classifying neuronal subclasses of the cerebellum through constellation pharmacology.

Authors:  Kigen J Curtice; Lee S Leavitt; Kevin Chase; Shrinivasan Raghuraman; Martin P Horvath; Baldomero M Olivera; Russell W Teichert
Journal:  J Neurophysiol       Date:  2015-11-18       Impact factor: 2.714

3.  The α7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat.

Authors:  G Munro; Rr Hansen; Hk Erichsen; Db Timmermann; Jk Christensen; Hh Hansen
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  ELIC-α7 Nicotinic acetylcholine receptor (α7nAChR) chimeras reveal a prominent role of the extracellular-transmembrane domain interface in allosteric modulation.

Authors:  Tommy S Tillman; Edom Seyoum; David D Mowrey; Yan Xu; Pei Tang
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

Review 5.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

6.  Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeper.

Authors:  Roger L Papke; Clare Stokes; Dustin K Williams; Jingyi Wang; Nicole A Horenstein
Journal:  Neuropharmacology       Date:  2010-07-27       Impact factor: 5.250

Review 7.  α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Authors:  Victor V Uteshev
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

8.  Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596.

Authors:  Bopanna I Kalappa; Alexander G Gusev; Victor V Uteshev
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

9.  Physiological concentrations of choline activate native alpha7-containing nicotinic acetylcholine receptors in the presence of PNU-120596 [1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)-urea].

Authors:  Alexander G Gusev; Victor V Uteshev
Journal:  J Pharmacol Exp Ther       Date:  2009-11-18       Impact factor: 4.030

10.  An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.

Authors:  Christopher B Marotta; Henry A Lester; Dennis A Dougherty
Journal:  Chem Biol       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.